Published in Ann Transplant on January 01, 2002
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell (2005) 2.98
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol (2007) 1.92
Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. Kardiol Pol (2009) 1.48
Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study. Urology (2013) 1.42
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med (2008) 1.26
Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res (2011) 1.04
Cancer Screening in Unprovoked Venous Thromboembolism. N Engl J Med (2015) 0.92
Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation (2002) 0.90
Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res (2005) 0.90
Statins impair glucose uptake in tumor cells. Neoplasia (2012) 0.90
Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. J Heart Valve Dis (2004) 0.89
Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia. Hypertens Res (2010) 0.88
Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol (2013) 0.87
A high red blood cell distribution width predicts failure of arteriovenous fistula. PLoS One (2012) 0.85
The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant (2003) 0.84
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemp Clin Trials (2007) 0.83
Urinary proteins, N-acetyl-β-D-glucosaminidase activity and estimated glomerular filtration rate in hypertensive patients with normoalbuminuria and microalbuminuria. Nephrology (Carlton) (2011) 0.82
Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students. Arch Med Sci (2010) 0.80
Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins. Mol Cell Biochem (2003) 0.80
Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously. Europace (2011) 0.80
Metabolism of collagen is altered in hypertensives with increased intima media thickness. Blood Press (2006) 0.78
[Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction]. Pol Arch Med Wewn (2003) 0.78
2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version. Kardiol Pol (2015) 0.78
Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1. PLoS One (2009) 0.78
Liddle syndrome caused by P616R mutation of the epithelial sodium channel beta subunit. Pediatr Nephrol (2005) 0.78
Does the control of negative emotions influence blood pressure control and its variability? Blood Press (2014) 0.77
The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients. Clin Exp Hypertens (2008) 0.77
SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry. Blood Press (2011) 0.77
[Erythromelalgia: two case reports and literature review]. Pol Arch Med Wewn (2007) 0.76
Analysis of PTEN mutation in non-familial pheochromocytoma. Ann N Y Acad Sci (2006) 0.76
The effect of statins on sympathetic activity: a meta-analysis. Clin Auton Res (2015) 0.76
[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol (2015) 0.76
Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis? J Heart Valve Dis (2007) 0.76
[Do adipocytokines cause hypertension?]. Kardiol Pol (2010) 0.75
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study. Eur Heart J (2005) 0.75
[Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women]. Pol Arch Med Wewn (2002) 0.75
[Awareness of the risks of hypertension in Poland: current status and ways to improve]. Kardiol Pol (2012) 0.75
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol (2016) 0.75
[Alagille syndrome and chronic renal failure]. Pol Arch Med Wewn (2003) 0.75
[Heart failure following lumbar surgery]. Pol Arch Med Wewn (2004) 0.75
Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland. J Appl Genet (2005) 0.75
[Assessment of renal arteries in patients suspected of having renovascular hypertension: comparison of Doppler sonography with multiphase MR angiography]. Przegl Lek (2004) 0.75
Laparoscopic treatment of adrenal cysts - own research and literature review. Endokrynol Pol (2015) 0.75
Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis. Cardiol J (2010) 0.75
[Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol (2016) 0.75
Resistant: hypertension, patient, or physician? Pol Arch Med Wewn (2015) 0.75
Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants (DOACs) - 2017 management proposals in Poland. Pol Arch Intern Med (2017) 0.75
Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases. Transpl Int (2003) 0.75
Catecholamine excretion and circadian blood pressure profile in patients with pheochromocytoma. Ann N Y Acad Sci (2006) 0.75